Peter F Lebowitz's most recent trade in BridgeBio Oncology Therapeutics Inc. was a trade of 7,289 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Inc | Peter F Lebowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 7,289 | 7,289 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Oncology Therapeutics Inc | Peter F Lebowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2026 | 63,350 | 63,350 | - | - | Stock Option (Right to Buy) |